AN OPEN-LABEL, RANDOMIZED, ADAPTIVE, TWO-ARM, MULTICENTE

Project: Research project

Project Details

Description

AN OPEN-LABEL, RANDOMIZED, ADAPTIVE, TWO-ARM, MULTICENTER TRIAL TO EVALUATE PHARMACOKINETICS AND PHARMACODYNAMICS OF TWO DOSES OF OSELTAMIVIR (TAMIFLU) IN THE TREATMENT OF INFLUENZA IN IMMUNOCOMPROMISED CHILDREN LESS THAN 13 YEARS OF AGE, WITH
StatusFinished
Effective start/end date8/1/166/30/20

Funding

  • HOFFMANN-LA ROCHE PHARMACEUTICALS

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.